Sevoflurane inhibits the μ-opioid receptor function expressed in xenopus oocytes

Pharmacology

Volumn 88, Issue 3-4, 2011, Pages 127-132

  Minami, Kouichiro ^a,c   Sudo, Yuka ^b,c   Yokoyama, Toru ^a,c   Ogata, Junichi ^a,c   Takeuchi, Mamoru ^a   Uezono, Yasuhito ^c  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Opioid receptor; G i o protein coupled receptors; Sevoflurane; Xenopus oocyte

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; MU OPIATE RECEPTOR; PROTEIN KINASE C; SEVOFLURANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; FEMALE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; XENOPUS;

ALUMINUM COMPOUNDS; ANALGESICS, OPIOID; ANESTHETICS, INHALATION; ANIMALS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; FEMALE; FLUORIDES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; INDOLES; MALEIMIDES; METHYL ETHERS; OOCYTES; PATCH-CLAMP TECHNIQUES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RECEPTORS, OPIOID, MU; RECOMBINANT FUSION PROTEINS; XENOPUS LAEVIS;

EID: 80052570760     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000330096     Document Type: Article

References (29)

1. Dahan A, Sarton E, Teppema L, Olievier C, Nieuwenhuijs D, Matthes HW, Kieffer BL: Anesthetic potency and influence of morphine and sevoflurane on respiration in muopioid receptor knockout mice. Anesthesiology 2001; 94: 824-832. (Pubitemid 32429753)
2. Katoh T, Uchiyama T, Ikeda K. Effect of fentanyl on awakening concentration of sevoflurane. Br J Anaesth 1994; 73: 322-325. (Pubitemid 24267427)
3. Katoh T, Ikeda K: The effects of fentanyl on sevoflurane requirements for loss of consciousness and skin incision. Anesthesiology 1998; 88: 18-24. (Pubitemid 128721127)
4. Koyama T, Mayahara T, Wakamatsu T, Sora I, Fukuda K: Deletion of mu-opioid receptor in mice does not affect the minimum alveolar concentration of volatile anaesthetics and nitrous oxide-induced analgesia. Br J Anaesth 2009; 103: 744-749.
5. Surratt CK, Adams WR: G protein-coupled receptor structural motifs: relevance to the opioid receptors. Curr Top Med Chem 2005; 5: 315-324. (Pubitemid 40614132)
6. Durieux ME: Muscarinic signaling in the central nervous system: recent developments and anesthetic implications. Anesthesiology 1996; 84: 173-189. (Pubitemid 26034434)
7. Minami K, Uezono Y: Gq protein-coupled receptors as targets for anesthetics. Curr Pharm Des 2006; 12: 1931-1937.
8. Minami K, Uezono Y, Ueta Y: Pharmacological aspects of the effects of tramadol on Gprotein coupled receptors. J Pharmacol Sci 2007; 103: 253-260. (Pubitemid 46465767)
9. Minami K, Gereau RW IV, Minami M, Heinemann SF, Harris RA: Effects of ethanol and anesthetics on type 1 and 5 metabotropic glutamate receptors expressed in Xenopus laevis oocytes. Mol Pharmacol 1998; 53: 148-156. (Pubitemid 28068383)
10. Minami K, Minami M, Harris RA: Inhibition of 5-hydroxytryptamine type 2A receptor-induced currents by n-alcohols and anesthetics. J Pharmacol Exp Ther 1997; 281: 1136-1143. (Pubitemid 27258370)
11. Minami K, Shiraishi M, Uezono Y, Ueno S, Shigematsu A: The inhibitory effects of anesthetics and ethanol on substance P receptors expressed in Xenopus oocytes. Anesth Analg 2002; 94: 79-83. (Pubitemid 34038723)
12. Minami K, Sudo Y, Shiraishi S, Seo M, Uezono Y: Analysis of the effects of anesthetics and ethanol on-opioid receptor. J Pharmacol Sci 2010; 112: 424-431.
13. Caulfield MP, Birdsall NJ: International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 1998; 50: 279-290. (Pubitemid 28304029)
14. Dascal N: The use of Xenopus oocytes for the study of ion channels. CRC Crit Rev Biochem 1987; 22: 317-387.
15. Hojo M, Sudo Y, Ando Y, Minami K, Takada M, Matsubara T, Kanaide M, Taniyama K, Sumikawa K, Uezono Y: mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis. J Pharmacol Sci 2008; 108: 308-319.
16. Vorobiov D, Bera AK, Keren-Raifman T, Barzilai R, Dascal N: Coupling of the muscarinic m2 receptor to G protein-activated K(+) channels via Galpha(z) and a receptor-Galpha(z) fusion protein: fusion between the receptor and Galpha(z) eliminates catalytic (collision) coupling. J Biol Chem 2000; 275: 4166-4170. (Pubitemid 30094650)
17. Minami K, Uezono Y, Sakurai T, Horishita T, Shiraishi M, Ueta Y: Effects of anesthetics on the function of orexin-1 receptors expressed in Xenopus oocytes. Pharmacology 2007; 79: 236-242. (Pubitemid 46848543)
18. Minami K, Uezono Y, Shiraishi M, Okamoto T, Ogata J, Horishita T, Taniyama K, Shigematsu A: Analysis of the effects of halothane on Gi-coupled muscarinic M 2 receptor signaling in Xenopus oocytes using a chimeric G alpha protein. Pharmacology 2004; 72: 205-212. (Pubitemid 39370250)
19. Minami K, Vanderah TW, Minami M, Harris RA: Inhibitory effects of anesthetics and ethanol on muscarinic receptors expressed in Xenopus oocytes. Eur J Pharmacol 1997; 339: 237-244. (Pubitemid 28021872)
20. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J: The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991; 266: 15771-15781. (Pubitemid 21907725)
21. Gilman AG: G proteins: transducers of receptor-generated signals. Annu Rev Biochem 1987; 56: 615-649.
22. Frink EJ Jr, Malan TP, Atlas M, Dominguez LM, DiNardo JA, Brown BR Jr: Clinical comparison of sevoflurane and isoflurane in healthy patients. Anesth Analg 1992; 74: 241-245.
23. Holaday DA, Smith FR: Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology 1981; 54: 100-106. (Pubitemid 11170337)
24. Smith FL, Gabra BH, Smith PA, Redwood MC, Dewey WL: Determination of the role of conventional, novel and atypical PKC isoforms in the expression of morphine tolerance in mice. Pain 2007; 127: 129-139. (Pubitemid 44959434)
25. Smith FL, Javed RR, Elzey MJ, Dewey WL: The expression of a high level of morphine antinociceptive tolerance in mice involves both PKC and PKA. Brain Res 2003; 985: 78-88. (Pubitemid 37272054)
26. Zeitz KP, Malmberg AB, Gilbert H, Basbaum AI: Reduced development of tolerance to the analgesic effects of morphine and clonidine in PKC gamma mutant mice. Pain 2001; 94: 245-253. (Pubitemid 33145394)
27. Kelly E, Bailey CP, Henderson G: Agonistselective mechanisms of GPCR desensitization. Br J Pharmacol 2008; 153(suppl 1):S379-S388.
28. Hasegawa J, Takekoshi S, Nagata H, Osamura RY, Suzuki T: Sevoflurane stimulates MAP kinase signal transduction through the activation of PKC alpha and betaII in fetal rat cerebral cortex cultured neuron. Acta Histochem Cytochem 2006; 39: 163-172. (Pubitemid 46049733)
29. Bouwman RA, Musters RJ, van Beek-Harmsen BJ, de Lange JJ, Lamberts RR, Loer SA, Boer C: Sevoflurane-induced cardioprotection depends on PKC-alpha activation via production of reactive oxygen species. Br J Anaesth 2007; 99: 639-645. (Pubitemid 351773204)